Published in Mayo Clin Proc on May 01, 1994
Safety and Efficacy of AST-120 in the Treatment of Pouchitis | NCT00583076
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut (2004) 3.01
The bacteriology of pouchitis: a molecular phylogenetic analysis using 16S rRNA gene cloning and sequencing. Ann Surg (2010) 1.69
Expression quantitative trait loci analysis identifies associations between genotype and gene expression in human intestine. Gastroenterology (2013) 1.69
MicroRNAs Expression in the Ileal Pouch of Patients with Ulcerative Colitis Is Robustly Up-Regulated and Correlates with Disease Phenotypes. PLoS One (2016) 1.38
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut (2006) 1.36
Gastroduodenitis associated with ulcerative colitis. J Gastroenterol (2008) 1.05
On the benefit of probiotics in the management of pouchitis in patients underwent ileal pouch anal anastomosis: a meta-analysis of controlled clinical trials. Dig Dis Sci (2007) 1.04
Complications of ileoanal pouches. Clin Colon Rectal Surg (2004) 0.99
The effect of sampling and storage on the fecal microbiota composition in healthy and diseased subjects. PLoS One (2015) 0.98
Consecutive Monitoring of Fecal Calprotectin and Lactoferrin for the Early Diagnosis and Prediction of Pouchitis after Restorative Proctocolectomy for Ulcerative Colitis. Am J Gastroenterol (2015) 0.97
Multiphasic analysis of the temporal development of the distal gut microbiota in patients following ileal pouch anal anastomosis. Microbiome (2013) 0.96
One- or two-stage procedure for restorative proctocolectomy: rationale for a surgical strategy in ulcerative colitis. Ann Surg (2001) 0.93
Characterization of the gut-associated microbiome in inflammatory pouch complications following ileal pouch-anal anastomosis. PLoS One (2013) 0.92
Combined carriership of TLR9-1237C and CD14-260T alleles enhances the risk of developing chronic relapsing pouchitis. World J Gastroenterol (2005) 0.91
Acute and chronic pouchitis--pathogenesis, diagnosis and treatment. Nat Rev Gastroenterol Hepatol (2012) 0.90
Rifaximin for maintenance therapy in antibiotic-dependent pouchitis. BMC Gastroenterol (2008) 0.88
Ulcer associated cell lineage glands expressing trefoil peptide genes are induced by chronic ulceration in ileal pouch mucosa. Gut (2001) 0.87
Pouchitis. World J Gastroenterol (2007) 0.87
Defensin expression in chronic pouchitis in patients with ulcerative colitis or familial adenomatous polyposis coli. World J Gastroenterol (2006) 0.87
Portal vein thrombi after ileal pouch-anal anastomosis: its incidence and association with pouchitis. Surg Today (2007) 0.86
The bacterial pathogenesis and treatment of pouchitis. Therap Adv Gastroenterol (2010) 0.86
Probiotics in inflammatory bowel diseases and associated conditions. Nutrients (2011) 0.85
The effect of Clostridium butyricum MIYAIRI on the prevention of pouchitis and alteration of the microbiota profile in patients with ulcerative colitis. Surg Today (2015) 0.84
Increased cytokine transcripts in pouchitis reflect the degree of inflammation but not the underlying entity. Int J Colorectal Dis (2005) 0.84
Differential expression of toll-like receptor 3 and 5 in ileal pouch mucosa of ulcerative colitis patients. Int J Colorectal Dis (2006) 0.83
Activation of signal-transducer and activator of transcription 1 (STAT1) in pouchitis. Clin Exp Immunol (2001) 0.83
Differential expression of pro-inflammatory cytokines and a pro-apoptotic protein in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis. Tech Coloproctol (2008) 0.83
Human lymphocyte stimulation with pouchitis flora is greater than with flora from a healthy pouch but is suppressed by metronidazole. Gut (2004) 0.83
Use of Biologics in Pouchitis: A Systematic Review. J Clin Gastroenterol (2015) 0.83
B1a lymphocytes in ulcerative colitis. Int J Colorectal Dis (2007) 0.82
The clinical impact of primary sclerosing cholangitis in patients with an ileal pouch-anal anastomosis for ulcerative colitis. Int J Colorectal Dis (2011) 0.82
Do probiotics have a therapeutic role in gastroenterology? World J Gastroenterol (2006) 0.82
The role of probiotics in inflammatory bowel disease. Dig Dis Sci (2007) 0.82
Prevalence and outcome of anemia after restorative proctocolectomy: a clinical literature review. Dis Colon Rectum (2009) 0.82
Antineutrophil cytoplasmic antibodies in sera from colectomised ulcerative colitis patients and its relation to the presence of pouchitis. Gut (1996) 0.82
Relationship between pouch microbiota and pouchitis following restorative proctocolectomy for ulcerative colitis. World J Gastroenterol (2014) 0.82
Diagnosis and treatment of pouchitis. Gastroenterol Hepatol (N Y) (2008) 0.81
Effect of withdrawal of nonsteroidal anti-inflammatory drug use on ileal pouch disorders. Dig Dis Sci (2007) 0.81
Anorectal complications and function in patients suffering from inflammatory bowel disease: a series of patients with long-term follow-up. Int J Colorectal Dis (2014) 0.81
Differential expression of TLR2, TLR4 and JNK in mucosa of ileal pouches for ulcerative colitis. Is there a role for bacterial antigen pathway in asymptomatic patients? Int J Clin Exp Med (2011) 0.80
Diet of patients after pouch surgery may affect pouch inflammation. World J Gastroenterol (2013) 0.80
Pouchitis atlas for objective endoscopic diagnosis. J Gastroenterol (2007) 0.80
Inflamed pouch mucosa possesses altered tight junctions indicating recurrence of inflammatory bowel disease. Int J Colorectal Dis (2009) 0.80
Pouchitis disease activity index (PDAI) does not predict patients with symptoms of pouchitis who will respond to antibiotics. Surg Today (2009) 0.80
A prospective analysis of clinical variables, serologic factors, and outcome of ileal pouch-anal anastomosis in patients with backwash ileitis. Dis Colon Rectum (2010) 0.79
Antibiotics and probiotics in chronic pouchitis: a comparative proteomic approach. World J Gastroenterol (2010) 0.79
Activation of signal transducer and activator of transcription-1 (STAT-1) and differential expression of interferon-gamma and anti-inflammatory proteins in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis. Clin Exp Immunol (2010) 0.79
Detection of epithelial apoptosis in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis. J Transl Med (2010) 0.78
Self-reported assessment of health-related quality of life in children who underwent restorative proctocolectomy with ileal J-pouch anal anastomosis for ulcerative colitis. Pediatr Surg Int (2012) 0.78
Utility of fecal and serum anti-Saccharomyces cerevisiae antibodies in the diagnosis of Crohn's disease-like condition of the pouch. Int J Colorectal Dis (2012) 0.78
Leukocytapheresis for the treatment of active pouchitis: a pilot study. J Gastroenterol (2008) 0.78
The diameter of the ileal J-pouch-anal anastomosis as an important risk factor of pouchitis - clinical observations. Med Sci Monit (2011) 0.78
Biopsychosocial predictors of fatigue in quiescent and mild ulcerative colitis - an explorative study. Psychosoc Med (2005) 0.78
Persistence of high CD40 and CD40L expression after restorative proctocolectomy for ulcerative colitis. World J Gastroenterol (2005) 0.78
CXC and CC chemokine expression in inflamed and noninflamed pelvic ileal pouch tissue. Int J Colorectal Dis (2003) 0.77
Family history of Crohn's disease is associated with an increased risk for Crohn's disease of the pouch. Inflamm Bowel Dis (2009) 0.77
The prognosis of clinical course and the analysis of the frequency of the inflammation and dysplasia in the intestinal J-pouch at the patients after restorative proctocolectomy due to FAP. Int J Colorectal Dis (2011) 0.77
Clinical value of surveillance pouchoscopy in asymptomatic ileal pouch patients with underlying inflammatory bowel disease. Surg Endosc (2013) 0.76
Microbiome Heterogeneity Characterizing Intestinal Tissue and Inflammatory Bowel Disease Phenotype. Inflamm Bowel Dis (2016) 0.76
Restorative proctocolectomy for inflammatory bowel disease: the Padova prognostic score for colitis in predicting long-term outcome and quality of life. Int J Colorectal Dis (2009) 0.76
Inflammatory pouch disease: The spectrum of pouchitis. World J Gastroenterol (2015) 0.76
Ileal lesions in patients with ulcerative colitis after ileo-rectal anastomosis: relationship with colonic metaplasia. World J Gastroenterol (2008) 0.76
Pouchitis and pre-pouch ileitis developed after restorative proctocolectomy for ulcerative colitis: a case report. World J Gastroenterol (2007) 0.76
Serial Fecal Calprotectin and Lactoferrin Measurements for Early Diagnosis of Pouchitis After Proctocolectomy for Ulcerative Colitis: Is Pouchoscopy No Longer Needed? Am J Gastroenterol (2015) 0.76
Surgical prophylaxis of pouchitis in ulcerative colitis. Dig Dis Sci (2010) 0.76
Clinical features and management of pouchitis in Japanese ulcerative colitis patients. Surg Today (2012) 0.75
Common Inflammatory Disorders and Neoplasia of the Ileal Pouch: A Review of Histopathology. Gastroenterology Res (2016) 0.75
Impairment of epithelial transport but not of barrier function in idiopathic pouchitis after ulcerative colitis. Gut (2002) 0.75
Endoscopy in inflammatory bowel disease when and why. World J Gastrointest Endosc (2012) 0.75
Alicaforsen, an antisense inhibitor of ICAM-1, as treatment for chronic refractory pouchitis after proctocolectomy: A case series. United European Gastroenterol J (2015) 0.75
A Distinct Colon-Derived Breath Metabolome is Associated with Inflammatory Bowel Disease, but not its Complications. Clin Transl Gastroenterol (2016) 0.75
Fecal Microbiota Transfer in Patients With Chronic Antibiotic-Refractory Pouchitis. Am J Gastroenterol (2016) 0.75
Efficacy of granulocyte and monocyte apheresis for antibiotic-refractory pouchitis after proctocolectomy for ulcerative colitis: an open-label, prospective, multicentre study. Therap Adv Gastroenterol (2016) 0.75
Histopathological evaluation and risk factors related to the development of pouchitis in patients with ileal pouches for ulcerative colitis. Clinics (Sao Paulo) (2012) 0.75
Association between gastro-intestinal symptoms and menstruation in patients with ileal pouches. Gastroenterol Rep (Oxf) (2014) 0.75
Local regulation of postprandial motor responses in ileal pouches. Gut (1999) 0.75
Fecal microbiota in pouchitis and ulcerative colitis. World J Gastroenterol (2016) 0.75
The Failed J Pouch. Clin Colon Rectal Surg (2016) 0.75
Pouch-Related Symptoms and Quality of Life in Patients with Ileal Pouch-Anal Anastomosis. Inflamm Bowel Dis (2017) 0.75
[Surgical strategy to save ileoanal pouch reconstruction]. Chirurg (2017) 0.75
Sulfasalazine in Prevention of Pouchitis After Proctocolectomy with Ileal Pouch-Anal Anastomosis for Ulcerative Colitis. Dig Dis Sci (2017) 0.75
Altered expression of microRNAs in patients with pouchitis after restorative proctocolectomy. Surg Today (2017) 0.75
Transmural inflammation is not pathognomonic for Crohn's disease of the pouch. Surg Endosc (2011) 0.75
Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med (1987) 7.73
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology (1999) 5.75
Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut (1990) 4.60
Simplified assessment of segmental colonic transit. Gastroenterology (1987) 4.59
Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology (1998) 4.52
Colonic secretion of water and electrolytes induced by bile acids: perfusion studies in man. J Clin Invest (1971) 4.18
Some aspects of anal continence and defaecation. Gut (1965) 4.02
Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Gastroenterology (2001) 3.85
A patient questionnaire to identify bowel disease. Ann Intern Med (1989) 3.43
Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc (1990) 3.34
Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1997) 3.29
Hereditary angioedema: a broad review for clinicians. Arch Intern Med (2001) 2.92
Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut (2000) 2.86
Increased reflux of bile into the stomach in patients with gastric ulcer. Gastroenterology (1969) 2.86
Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. Inflamm Bowel Dis (2001) 2.80
Altered small bowel motility in irritable bowel syndrome is correlated with symptoms. Gastroenterology (1987) 2.80
Liver iron stores in patients with non-insulin-dependent diabetes mellitus. Mayo Clin Proc (1994) 2.71
Prevalence of Helicobacter pylori in specific forms of gastritis. Further evidence supporting a pathogenic role for H. pylori in chronic nonspecific gastritis. Dig Dis Sci (1991) 2.67
Brunner's gland hamartomas: clinical presentation and pathological features of 27 cases. Am J Gastroenterol (1995) 2.52
Perfusion of the canine colon with unconjugated bile acids. Effect on water and electrolyte transport, morphology, and bile acid absorption. Gastroenterology (1970) 2.43
Outcome of "indeterminant" colitis following ileal pouch-anal anastomosis. Dis Colon Rectum (1989) 2.41
Diagnosis and monitoring of Whipple disease by polymerase chain reaction. Ann Intern Med (1997) 2.38
Intraductal papillary-mucinous tumors of the pancreas: clinicopathologic features, outcome, and nomenclature. Members of the Pancreas Clinic, and Pancreatic Surgeons of Mayo Clinic. Gastroenterology (1996) 2.33
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut (2005) 2.22
Non-ulcer dyspepsia: potential causes and pathophysiology. Ann Intern Med (1988) 2.17
J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients. Br J Surg (1998) 2.15
Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet (1992) 2.15
Management of colonoscopic perforations. Mayo Clin Proc (1997) 2.13
Relation among personality and symptoms in nonulcer dyspepsia and the irritable bowel syndrome. Gastroenterology (1990) 2.09
Conservation of sodium, chloride, and water by the human colon. Gastroenterology (1969) 2.08
Human interdigestive motility: variations in patterns from esophagus to colon. Gastroenterology (1986) 2.00
A comparison of stable and 14 C-labelled polyethylene glycol as volume indicators in the human jejunum. Gut (1972) 1.98
Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis. Ann Surg (1990) 1.93
Control of gastric emptying by osmolality of duodenal contents in man. Gastroenterology (1975) 1.92
Effects of oleic and ricinoleic acids on net jejunal water and electrolyte movement. Perfusion studies in man. J Clin Invest (1974) 1.92
Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). II. Application to normal and abnormal permeability states in man and animals. Gastroenterology (1977) 1.92
Transit of solids through the human colon: regional quantification in the unprepared bowel. Am J Physiol (1990) 1.90
Effects of an irritable bowel syndrome educational class on health-promoting behaviors and symptoms. Am J Gastroenterol (1998) 1.88
The contribution of the colon to electrolyte and water conservation in man. J Lab Clin Med (1973) 1.88
AGA technical review on constipation. American Gastroenterological Association. Gastroenterology (2000) 1.87
Occlusion of the jejunum for intestinal perfusion in man. Mayo Clin Proc (1966) 1.85
Capacity of the human colon to absorb fluid. Gastroenterology (1978) 1.85
Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group. Gastroenterology (1999) 1.84
Primary extrapulmonary sugar tumor (PEST): a report of four cases. Mod Pathol (2001) 1.82
Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-1982. Gut (1988) 1.82
Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg (1995) 1.82
Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study. Gastroenterology (1997) 1.80
Misdiagnosis of specific cytomegalovirus infection of the ileoanal pouch as refractory idiopathic chronic pouchitis: report of two cases. Dis Colon Rectum (1999) 1.79
Surgical treatment of adenocarcinoma of the rectum. Ann Surg (1998) 1.77
How well does stool form reflect colonic transit? Gut (1996) 1.77
Quality of life after proctocolectomy. A comparison of Brooke ileostomy, Kock pouch, and ileal pouch-anal anastomosis. Gastroenterology (1991) 1.77
Urinary retention after operations for benign anorectal diseases. Dis Colon Rectum (1998) 1.76
American Gastroenterological Association Medical Position Statement: guidelines on constipation. Gastroenterology (2000) 1.74
Cytogenetic analysis of six renal oncocytomas and a chromophobe cell renal carcinoma. Evidence that -Y, -1 may be a characteristic anomaly in renal oncocytomas. Cancer Genet Cytogenet (1992) 1.73
Studies of the perfusion technique for colonic absorption. Gastroenterology (1969) 1.73
Human gastric emptying and colonic filling of solids characterized by a new method. Am J Physiol (1989) 1.73
Passage of carbohydrate into the colon. Direct measurements in humans. Gastroenterology (1983) 1.73
Effect of glycine-conjugated bile acids with and without lecithin on water and glucose absorption in perfused human jejunum. J Clin Invest (1973) 1.73
The long-term effect of adjuvant postoperative chemoradiotherapy for rectal carcinoma on bowel function. Ann Surg (1994) 1.72
Risk of lymphoma in inflammatory bowel disease. Am J Gastroenterol (2000) 1.71
Diagnostic value of the Manning criteria in irritable bowel syndrome. Gut (1990) 1.68
Chronic ulcerative colitis: incidence and prevalence in a community. Gut (1987) 1.66
Ischemic cholangitis in hepatic allografts. Mayo Clin Proc (1992) 1.66
Ileal pouch-anal anastomosis: comparison of results in familial adenomatous polyposis and chronic ulcerative colitis. Ann Surg (1989) 1.64
Outcomes following surgery without radiotherapy for rectal cancer. Br J Surg (2011) 1.64
Straight ileoanal anastomosis v ileal pouch--anal anastomosis after colectomy and mucosal proctectomy. Arch Surg (1983) 1.63
Variability of gastrointestinal transit in healthy women and men. Gut (1996) 1.63
Adenosquamous and squamous carcinoma of the colon and upper rectum: a clinical and histopathologic study. Dis Colon Rectum (2001) 1.63
Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry. Neurogastroenterol Motil (2009) 1.62
Active and passive bile acid absorption in man. Perfusion studies of the ileum and jejunum. J Clin Invest (1974) 1.62
Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: results of a pilot study. Mayo Clin Proc (1996) 1.61
Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohort. Gastroenterology (1999) 1.61
Nonsteroidal anti-inflammatory drug-induced enteropathy: case discussion and review of the literature. Mayo Clin Proc (1995) 1.59
Does Helicobacter pylori colonize the gastric mucosa of Meckel's diverticulum? Mayo Clin Proc (1990) 1.59
Scintigraphy of the whole gut: clinical evaluation of transit disorders. Mayo Clin Proc (1995) 1.58
Perfusion of the hamster jejunum with conjugated and unconjugated bile acids: inhibition of water absorption and effects on morphology. Gastroenterology (1972) 1.58
Long-term results of surgery for chronic constipation. Dis Colon Rectum (1997) 1.58
Physiologic aspects of continence after colectomy, mucosal proctectomy, and endorectal ileo-anal anastomosis. Ann Surg (1982) 1.57
Effect of molecular structure on bile acid-induced alterations in absorptive function, permeability, and morphology in the perfused rabbit colon. J Lab Clin Med (1979) 1.57
Successful management of Crohn's disease of the ileoanal pouch with infliximab. Gastroenterology (1999) 1.56
Removal of the anus during proctectomy. Br J Surg (1997) 1.56
Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology (2000) 1.55
Maintenance of symptomatic remission in patients with Crohn's disease. Mayo Clin Proc (1993) 1.54
Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis. Hepatology (1999) 1.54
Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation. Hepatology (1993) 1.53
Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study. Mayo Clin Proc (1992) 1.53
Clinical management of intractable constipation. Ann Intern Med (1994) 1.52
Inhibition of ileal water absorption by intraluminal fatty acids. Influence of chain length, hydroxylation, and conjugation of fatty acids. J Clin Invest (1974) 1.51
Achievable benchmarks of care: the ABCs of benchmarking. J Eval Clin Pract (1999) 1.51
A hypothesis of anal continence. Proc R Soc Med (1965) 1.50
A clinico-physiological comparison of ileal pouch-anal and straight ileoanal anastomoses. Ann Surg (1983) 1.50
The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy. Hepatology (1996) 1.48
A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn's perianal fistulas. Gastroenterology (2001) 1.47
Colonic tone and motility in patients with irritable bowel syndrome. Mayo Clin Proc (1992) 1.46
Intravenous azathioprine in severe ulcerative colitis: a pilot study. Am J Gastroenterol (2000) 1.46